ArticleFrontiers in public health2025

Can the accepting foreign clinical data policy improve innovation investment of pharmaceutical firms? Empirical evidence from China.

Mengjuan Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.